BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27404458)

  • 1. Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity.
    De Flora S; Camoirano A; Micale RT; La Maestra S; Savarino V; Zentilin P; Marabotto E; Suh M; Proctor DM
    Toxicol Appl Pharmacol; 2016 Sep; 306():113-9. PubMed ID: 27404458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of hexavalent chromium by fasted and fed human gastric fluid. II. Ex vivo gastric reduction modeling.
    Kirman CR; Suh M; Hays SM; Gürleyük H; Gerads R; De Flora S; Parker W; Lin S; Haws LC; Harris MA; Proctor DM
    Toxicol Appl Pharmacol; 2016 Sep; 306():120-33. PubMed ID: 27396814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hexavalent chromium reduction kinetics in rodent stomach contents.
    Proctor DM; Suh M; Aylward LL; Kirman CR; Harris MA; Thompson CM; Gürleyük H; Gerads R; Haws LC; Hays SM
    Chemosphere; 2012 Oct; 89(5):487-93. PubMed ID: 22682893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexavalent chromium reduction with scrap iron in continuous-flow system Part 1: effect of feed solution pH.
    Gheju M; Iovi A; Balcu I
    J Hazard Mater; 2008 May; 153(1-2):655-62. PubMed ID: 17933460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ingestion of chromium(VI) in drinking water by human volunteers: absorption, distribution, and excretion of single and repeated doses.
    Kerger BD; Finley BL; Corbett GE; Dodge DG; Paustenbach DJ
    J Toxicol Environ Health; 1997 Jan; 50(1):67-95. PubMed ID: 9015133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A revised model of ex-vivo reduction of hexavalent chromium in human and rodent gastric juices.
    Schlosser PM; Sasso AF
    Toxicol Appl Pharmacol; 2014 Oct; 280(2):352-61. PubMed ID: 25151221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and kinetics of hexavalent chromium reduction by gallic acid in aqueous solutions.
    Chen Z; Zhao Y; Li Q
    Water Sci Technol; 2015; 71(11):1694-700. PubMed ID: 26038935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human health risk and exposure assessment of chromium (VI) in tap water.
    Paustenbach DJ; Finley BL; Mowat FS; Kerger BD
    J Toxicol Environ Health A; 2003 Jul; 66(14):1295-339. PubMed ID: 12851114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human ingestion of chromium (VI) in drinking water: pharmacokinetics following repeated exposure.
    Finley BL; Kerger BD; Katona MW; Gargas ML; Corbett GC; Paustenbach DJ
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):151-9. PubMed ID: 9007044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic insights from the NTP studies of chromium.
    Witt KL; Stout MD; Herbert RA; Travlos GS; Kissling GE; Collins BJ; Hooth MJ
    Toxicol Pathol; 2013 Feb; 41(2):326-42. PubMed ID: 23334696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the mutagenic potential of hexavalent chromium in the duodenum of big blue® rats.
    Thompson CM; Young RR; Dinesdurage H; Suh M; Harris MA; Rohr AC; Proctor DM
    Toxicol Appl Pharmacol; 2017 Sep; 330():48-52. PubMed ID: 28687238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium.
    Kirman CR; Hays SM; Aylward LL; Suh M; Harris MA; Thompson CM; Haws LC; Proctor DM
    Chem Biol Interact; 2012 Oct; 200(1):45-64. PubMed ID: 22981460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cr(VI) reduction in wastewater using a bimetallic galvanic reactor.
    Lugo-Lugo V; Barrera-Díaz C; Bilyeu B; Balderas-Hernández P; Ureña-Nuñez F; Sánchez-Mendieta V
    J Hazard Mater; 2010 Apr; 176(1-3):418-25. PubMed ID: 20031318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian reduction of chromium in the gastric environment.
    De Flora S; Badolati GS; Serra D; Picciotto A; Magnolia MR; Savarino V
    Mutat Res; 1987 Nov; 192(3):169-74. PubMed ID: 3683437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro reduction kinetics of hexavalent chromium in human blood.
    Corbett GE; Dodge DG; O'Flaherty E; Liang J; Throop L; Finley BL; Kerger BD
    Environ Res; 1998 Jul; 78(1):7-11. PubMed ID: 9630439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromium in drinking water: sources, metabolism, and cancer risks.
    Zhitkovich A
    Chem Res Toxicol; 2011 Oct; 24(10):1617-29. PubMed ID: 21766833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
    Quievryn G; Peterson E; Messer J; Zhitkovich A
    Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of hexavalent Cr in river sediments by speciated isotope dilution inductively coupled plasma mass spectrometry.
    Drinčić A; Zuliani T; Ščančar J; Milačič R
    Sci Total Environ; 2018 Oct; 637-638():1286-1294. PubMed ID: 29801221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review.
    Proctor DM; Otani JM; Finley BL; Paustenbach DJ; Bland JA; Speizer N; Sargent EV
    J Toxicol Environ Health A; 2002 May; 65(10):701-46. PubMed ID: 12028825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of hexavalent chromium reduction in anoxic estuarine sediments: pH effects and the role of acid volatile sulfides.
    Graham AM; Bouwer EJ
    Environ Sci Technol; 2010 Jan; 44(1):136-42. PubMed ID: 20039744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.